CJ
CHIMAKURTHY JITHENDRA
Vignan's Foundation for Science, Technology and Research, ACHARYA NAGARUJUNA UNIVERSITY, CL BAID METHA COLLEGE OF PHARMACY
0000-0002-2948-4948
Employment
-
Vignan's Foundation for Science, Technology and Research Head2017 - Present
Education
-
ACHARYA NAGARUJUNA UNIVERSITY DOCTOR OF PHILOSOPHY2008 - 2012
-
CL BAID METHA COLLEGE OF PHARMACY MASTER OF PHARMACY PHARMACOLOGY2004 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- Preclinical Pharmacokinetics of Erdafitinib, an FGFR Tyrosine Kinase Inhibitor, via LC‐MS/MS in Sprague Dawley Rats Save
- Validated LC–MS/MS Method for the Quantitative Determination and Pharmacokinetic Profiling of Fedratinib (TG101348), an Oral JAK2 Inhibitor, in CD1 Mice Plasma Save
- Simultaneous Estimation of Avutometinib and Defactinib in Rat Plasma by Using LC–MS/MS and Its Application to Pharmacokinetic Studies Save
- Utilization of Camellia sinensis as a STAT inhibitor in the management and prevention of breast cancer: A review Save
- Quantification of Vactosertib an Inhibitor of TGFBR1 by LC–MS/MS in Rat Plasma and Its Pharmacokinetic Profiling Save
- Emerging Role of Biopharmaceutical Classification and Biopharmaceutical Drug Disposition System in Dosage form Development: A Systematic Review Save
- The role of body mass index or metabolic syndrome components causing depression in women: An observation from weight reduction clinical trial Save
- Microvascular Complications and Their Associated Risk Factors Among Rural Type 2 Diabetic Population: A Cross-Sectional Study Save
- Relationship between dopamine and serotonin on the effect of Ginkgo biloba extract in the treatment of obsessive-compulsive disorder in Rodents Save
- Design, Synthesis and Biological Evaluation of 2 (((5-aryl-1,2,4-oxadiazol-3-yl)methyl)thio)benzo[d]oxazoles: New Antiinflammatory and Antioxidant Agents Save